GHK-Cu Monitoring Schedule: Labs & Exams You Need At a glance Drug / GHK-Cu is a tripeptide-copper(II) complex first isolated from human plasma albumin Route / subcutaneous injection or topical (compounded under FDA section 503A) Baseline labs / serum copper, ceruloplasmin, CBC with differential, CMP including liver enzymes Recheck interval / 4 weeks after initiation, then every 8 to 12 weeks Normal serum copper / 70 to 140 g/dL (11 to 22 mol/L) Ceruloplasmin target / 20 to 35 mg/dL Liver enzymes / ALT and AST should remain below 2x upper limit of normal 24-hour urine copper / ordered if serum copper exceeds 155 g/dL on two consecutive draws Skin exam / baseline and every 12 weeks for subcutaneous injection sites Discontinuation trigger / serum copper above 200 g/dL or ceruloplasmin below 15 mg/dL How GHK-Cu Works: Mechanism Before Monitoring GHK-Cu is glycyl-L-histidyl-L-lysine bound to a single copper(II) ion
Try out our Glutathione IV Treatment Today
Endoscopic characteristics of UC loss of normal vascular markings and the presence of mucosal granularity, friability, exudates, and focal ulcerations Left- sided UC can be associated with isolated inflammation around the appendix (known as a cecal patch) Endoscopic characteristics of CDdeep linear ulcers, erythema, granularity, and skip lesions Colonoscopy with surveillance biopsies for malignancy should be performed after 8 to 10 years from diagnosis with subsequent surveillance every 1 to 2 years CT or MR enterography can be used to assess the location and extent of small-bowel disease in CD MR imagingthe preferred method for evaluation of pelvic and perianal abscesses Suggested Reading Fletcher JG, Fidler JL, Bruining DH, Huprich JE
For laboratory research applications, peptide purity and structural integrity are important factors affecting assay reproducibility and biochemical signaling studies
Thakore, P
